This process was mediated by signaling through CXCR2 in neutrophils (85), consistent with the observation that neutrophil recruitment and tumor progression are impaired in Cxcr2-deficient mice in several models of carcinoma (86). This evidence concerns the gene CXCR2 and neoplasm.